Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ad P Ijzerman

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Drug Development Research|January 19, 2024
1,3-Dialkylxanthine Derivatives Having High Potency as Antagonists at Human A<sub>2B</sub> Adenosine ReceptorsKenneth A Jacobson, Ad P IJzerman, Joel Linden
Neural Networks : the Official Journal of the International Neural Network Society|June 20, 2006
TreeSOM: Cluster analysis in the self-organizing mapElena V Samsonova, Joost N Kok, Ad P Ijzerman
Advances in Pharmacology (San Diego, Calif.)|September 13, 2011
Biological and pharmacological roles of HCA receptorsClara C Blad, Kashan Ahmed, Ad P IJzerman, et al.
Proteins|January 24, 2007
Characteristic amino acid combinations in olfactory G protein-coupled receptorsElena V Samsonova, Peter Krause, Thomas Bäck, et al.
Purinergic Signalling|December 10, 2015
Scintillation proximity assay (SPA) as a new approach to determine a ligand's kinetic profile. A case in point for the adenosine A1 receptorLizi Xia, Henk de Vries, Ad P IJzerman, et al.
Journal of Chemical Information and Modeling|March 28, 2006
The molecule evoluator. An interactive evolutionary algorithm for the design of drug-like moleculesEric-Wubbo Lameijer, Joost N Kok, Thomas Bäck, et al.
Journal of Chemical Information and Modeling|March 28, 2006
Mining a chemical database for fragment co-occurrence: discovery of "chemical clichés"Eric-Wubbo Lameijer, Joost N Kok, Thomas Bäck, et al.
Purinergic Signalling|October 12, 2012
Functional selectivity of adenosine A1 receptor ligands?Ellen V Langemeijer, Dennis Verzijl, Stefan J Dekker, et al.
Biochemical Pharmacology|August 12, 2009
The endocannabinoid 2-arachidonylglycerol is a negative allosteric modulator of the human A3 adenosine receptorJ Robert Lane, Margot W Beukers, Thea Mulder-Krieger, et al.
Purinergic Signalling|August 6, 2011
Three "hotspots" important for adenosine A(2B) receptor activation: a mutational analysis of transmembrane domains 4 and 5 and the second extracellular loopMiriam C Peeters, Qilan Li, Gerard J P van Westen, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Drug Development Research|January 19, 2024
1,3-Dialkylxanthine Derivatives Having High Potency as Antagonists at Human A<sub>2B</sub> Adenosine ReceptorsKenneth A Jacobson, Ad P IJzerman, Joel Linden
Neural Networks : the Official Journal of the International Neural Network Society|June 20, 2006
TreeSOM: Cluster analysis in the self-organizing mapElena V Samsonova, Joost N Kok, Ad P Ijzerman
Advances in Pharmacology (San Diego, Calif.)|September 13, 2011
Biological and pharmacological roles of HCA receptorsClara C Blad, Kashan Ahmed, Ad P IJzerman, et al.
Proteins|January 24, 2007
Characteristic amino acid combinations in olfactory G protein-coupled receptorsElena V Samsonova, Peter Krause, Thomas Bäck, et al.
Purinergic Signalling|December 10, 2015
Scintillation proximity assay (SPA) as a new approach to determine a ligand's kinetic profile. A case in point for the adenosine A1 receptorLizi Xia, Henk de Vries, Ad P IJzerman, et al.
Journal of Chemical Information and Modeling|March 28, 2006
The molecule evoluator. An interactive evolutionary algorithm for the design of drug-like moleculesEric-Wubbo Lameijer, Joost N Kok, Thomas Bäck, et al.
Journal of Chemical Information and Modeling|March 28, 2006
Mining a chemical database for fragment co-occurrence: discovery of "chemical clichés"Eric-Wubbo Lameijer, Joost N Kok, Thomas Bäck, et al.
Purinergic Signalling|October 12, 2012
Functional selectivity of adenosine A1 receptor ligands?Ellen V Langemeijer, Dennis Verzijl, Stefan J Dekker, et al.
Biochemical Pharmacology|August 12, 2009
The endocannabinoid 2-arachidonylglycerol is a negative allosteric modulator of the human A3 adenosine receptorJ Robert Lane, Margot W Beukers, Thea Mulder-Krieger, et al.
Purinergic Signalling|August 6, 2011
Three "hotspots" important for adenosine A(2B) receptor activation: a mutational analysis of transmembrane domains 4 and 5 and the second extracellular loopMiriam C Peeters, Qilan Li, Gerard J P van Westen, et al.
Pageof 6